Lewis Buss

3.5k total citations
25 papers, 237 citations indexed

About

Lewis Buss is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lewis Buss has authored 25 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lewis Buss's work include SARS-CoV-2 and COVID-19 Research (7 papers), Trypanosoma species research and implications (6 papers) and SARS-CoV-2 detection and testing (5 papers). Lewis Buss is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Trypanosoma species research and implications (6 papers) and SARS-CoV-2 detection and testing (5 papers). Lewis Buss collaborates with scholars based in Brazil, United Kingdom and United States. Lewis Buss's co-authors include Éster Cerdeira Sabino, Nuno R. Faria, Darlan da Silva Cândido, John R. Hurst, Tânia Regina Tozetto‐Mendoza, Cole Wayant, Maria Cássia Mendes-Corrêa, Fábio E. Leal, Moacyr Roberto Cucê Nobre and Carlos A. Prete and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Lewis Buss

24 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis Buss Brazil 10 106 57 51 50 24 25 237
Vernon J. M. Lee Singapore 8 224 2.1× 106 1.9× 92 1.8× 37 0.7× 19 0.8× 12 358
Jamie A. Cohen United States 6 61 0.6× 65 1.1× 42 0.8× 32 0.6× 19 0.8× 13 175
Thobeka Mngomezulu South Africa 6 106 1.0× 27 0.5× 39 0.8× 26 0.5× 40 1.7× 7 280
Hengameh Mojdeganlou Iran 7 178 1.7× 39 0.7× 33 0.6× 25 0.5× 12 0.5× 21 303
Nicholas Steyn New Zealand 13 149 1.4× 179 3.1× 68 1.3× 24 0.5× 42 1.8× 19 331
Jacques Lukenze Tamuzi South Africa 9 186 1.8× 23 0.4× 49 1.0× 59 1.2× 20 0.8× 43 288
Juliane F. Oliveira Brazil 12 106 1.0× 124 2.2× 48 0.9× 97 1.9× 47 2.0× 22 274
Anne Marie O’Connell United Kingdom 6 184 1.7× 50 0.9× 48 0.9× 20 0.4× 8 0.3× 9 274
Seungjae Lee South Korea 5 273 2.6× 96 1.7× 56 1.1× 19 0.4× 19 0.8× 9 408
Hengcong Liu China 6 136 1.3× 142 2.5× 49 1.0× 28 0.6× 33 1.4× 11 249

Countries citing papers authored by Lewis Buss

Since Specialization
Citations

This map shows the geographic impact of Lewis Buss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis Buss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis Buss more than expected).

Fields of papers citing papers by Lewis Buss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis Buss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis Buss. The network helps show where Lewis Buss may publish in the future.

Co-authorship network of co-authors of Lewis Buss

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis Buss. A scholar is included among the top collaborators of Lewis Buss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis Buss. Lewis Buss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabino, Éster Cerdeira, Lewis Buss, Clara Di Germanio, et al.. (2025). Bimodal distributions of anti-Trypanosoma cruzi antibody levels in blood donors are associated with parasite detection and antibody waning in peripheral blood. PLoS neglected tropical diseases. 19(5). e0012724–e0012724.
2.
Buss, Lewis, et al.. (2024). Female Genital Schistosomiasis (FGS) Prevalence and Burden Across Endemic Countries, Timelines, and Age Groups: A Retrospective Study. SHILAP Revista de lepidopterología. 4(4). 382–389. 2 indexed citations
3.
Dye, Christopher, Nuno R. Faria, Fábio E. Leal, et al.. (2023). Scale-free dynamics of COVID-19 in a Brazilian city. Applied Mathematical Modelling. 121. 166–184. 6 indexed citations
4.
Moreira, Carlos Henrique Valente, Ana Luiza Bierrenbach, César Augusto Taconeli, et al.. (2023). Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease. SHILAP Revista de lepidopterología. 2. 1235925–1235925. 2 indexed citations
5.
Buss, Lewis, et al.. (2023). Can I have blood tests to check everything is alright?. BMJ. 382. e075728–e075728. 2 indexed citations
6.
Prete, Carlos A., Lewis Buss, Renata Buccheri, et al.. (2022). Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil. BMC Infectious Diseases. 22(1). 127–127. 10 indexed citations
7.
Ferreira, Marcelo U., Priscila de Morais Sato, Bárbara Hatzlhoffer Lourenço, et al.. (2022). SARS-CoV-2 seropositivity and COVID-19 among 5 years-old Amazonian children and their association with poverty and food insecurity. PLoS neglected tropical diseases. 16(7). e0010580–e0010580. 3 indexed citations
8.
Franco, Lucas Augusto Moysés, Carlos Henrique Valente Moreira, Lewis Buss, et al.. (2021). Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole. International Journal of Molecular Sciences. 22(4). 1960–1960. 3 indexed citations
9.
Santos, Andreza Aruska de Souza, Darlan da Silva Cândido, William Marciel de Souza, et al.. (2021). Dataset on SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities. Scientific Data. 8(1). 73–73. 25 indexed citations
10.
Araújo, Leonardo José Tadeu de, Lewis Buss, Juliana Mariotti Guerra, et al.. (2021). Surveillance of hemorrhagic fever and/or neuroinvasive disease: challenges of diagnosis. Revista de Saúde Pública. 55. 41–41. 2 indexed citations
11.
Tozetto‐Mendoza, Tânia Regina, Kelly Aparecida Kanunfre, Anderson Vicente de Paula, et al.. (2021). Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?. Journal of Virological Methods. 290. 114064–114064. 13 indexed citations
12.
Leal, Fábio E., Maria Cássia Mendes-Corrêa, Lewis Buss, et al.. (2021). Clinical features and natural history of the first 2073 suspected COVID-19 cases in the Corona São Caetano primary care programme: a prospective cohort study. BMJ Open. 11(1). e042745–e042745. 22 indexed citations
13.
Nicolete, Vanessa C., Priscila T. Rodrigues, Rodrigo M. Corder, et al.. (2021). Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021. Emerging infectious diseases. 28(3). 709–712. 14 indexed citations
14.
Prete, Carlos A., Lewis Buss, Amy Dighe, et al.. (2020). Serial interval distribution of SARS-CoV-2 infection in Brazil. Journal of Travel Medicine. 28(2). 30 indexed citations
15.
Buss, Lewis, Carlos Henrique Valente Moreira, Erika R. Manuli, et al.. (2020). Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors. PLoS neglected tropical diseases. 14(10). e0008787–e0008787. 16 indexed citations
16.
Buss, Lewis, et al.. (2020). Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018. PLoS ONE. 15(7). e0236345–e0236345. 15 indexed citations
17.
Costa, Sílvia Figueiredo, Lewis Buss, José Mauro Vieira, et al.. (2020). Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country. Journal of Clinical Virology. 131. 104592–104592. 9 indexed citations
18.
Buss, Lewis, et al.. (2020). Attendance for diagnostic colposcopy among high‐risk human papillomavirus positive women in a Brazilian feasibility study. International Journal of Gynecology & Obstetrics. 152(1). 72–77. 8 indexed citations
19.
Guerra, Juliana Mariotti, Mariana Sequetin Cunha, Lewis Buss, et al.. (2020). One-step Multiplex Real-time RT-PCR for Molecular Detection and Typing of Dengue Virus Infection From Paraffin-embedded Tissues During the Brazilian 2019 Outbreak. Applied immunohistochemistry & molecular morphology. 29(2). 158–162. 4 indexed citations
20.
Buss, Lewis, Tricia M. McKeever, Jessica Nightingale, et al.. (2018). Outcomes post hip fracture for patients with COPD. PA4145–PA4145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026